Past Press Releases - Polyplus-transfection

October 28, 2014
Polyplus-transfection and Blue Sky BioServices sign a research and commercial license agreement
Polyplus-transfection and Blue Sky BioServices sign a research and commercial license agreement for use of PEI-based transfection technologies. More

January 10, 2011
Polyplus-transfection raises EUR 2.5 million in latest funding round
The additional funds will enable the company to expand its therapeutic research activities. More

September 8, 2010
Généthon to use Polyplus-transfection’s jetPEI transfection reagent for producing viral vectors
Polyplus-transfection, which specializes in the development of innovative solutions for cellular and molecular biology research, announced that Généthon, a not-for-profit biotherapy laboratory run by the French Muscular Dystrophy Association, has selected Polyplus-transfection’s jetPEI transfection reagent for the production of its viral vectors. More

May 18, 2010
Polyplus-transfection licenses Kempbio for mammalian transient transfection technology
Polyplus-transfection, a company developing solutions for molecular and cellular biology, announced today that Kempbio, Inc., a company providing bioservices to the biotechnology and biopharmaceutical industry, has signed a license agreement to use polyethylenimine (PEI) for the transfection of cells used for the production of recombinant proteins. More

March 2, 2010
Polyplus-transfection licenses ZNA oligonucleotide technology to metabion
ZNA technology provides for increased affinity for nucleic acids. More